The goal of this randomized controlled trial was to investigate the impact of Virtual Reality (VR) technology on depression, anxiety, and stress levels among Palestinian patients undergoing breast biopsy. The study aimed to evaluate the effectiveness of VR as a non-pharmacological intervention to reduce psychological distress associated with the biopsy procedure.
The main research hypotheses are:
H01: There will be no significant difference in depression levels between patients who receive immersive VR during breast biopsy and those who receive standard care.
H02: There will be no significant difference in anxiety levels between patients who receive immersive VR during breast biopsy and those who receive standard care.
H03: There will be no significant difference in stress levels between patients who receive immersive VR during breast biopsy and those who receive standard care.
Participants will:
Receive either a VR intervention or standard care during their breast biopsy. Wear a VR headset for 15-30 minutes, experiencing a calming virtual environment designed to promote relaxation.
Complete assessments of depression, anxiety, and stress before and after the procedure using validated psychological questionnaires.
Female patients scheduled to undergo a breast biopsy.
Patients older than 18 years.
Patients who are able to provide informed consent.
Patients with no prior history of severe psychiatric disorders that could affect the assessment of depression, anxiety, or stress.
Patients who have a history of severe psychiatric disorders, epilepsy, hypertension, or chronic pain.
Patients who are mute and cannot read or write, patients with visual, hearing, or cognitive impairment.
Patients who have implanted hearing aids or cardiac pacemakers.
Patients who will receive any anxiolytic, sedative, or hypnotic drugs before or during the procedure.